Roche posts IMpower010 results in resected NSCLC; adds polatuzumab real-world studySep 30Weekly roundup, 9 itemsafimkibartatezolizumabUpdated
Roche's Valium gets label update; trontinemab Alzheimer's trials continue as active, not recruitingSep 25Weekly roundup, 6 itemsChugai PharmaceuticaldiazepamUpdated
New Phase Ib myeloma study registered; GSK-linked FTD trial terminated, BRCA study postedSep 24Weekly roundup, 3 itemsAL001Alector, Inc.
Ionis and Roche report positive Phase 3 interim data for sefaxersen in IgA nephropathySep 23Clinical readoutIonis PharmaceuticalsRoche
Roche posts HCC trial results, registers five new studies across cancer, MS, flu, COPDSep 18Weekly roundup, 6 itemsbaloxavir marboxilcevostamab
Roche posts results for lebrikizumab COPD trial; crovalimab pediatric aHUS study nears completionSep 10Weekly roundup, 3 itemsChugai Pharmaceuticalcrovalimab
BioNTech ends Phase 2 trial of autogene cevumeran in colorectal cancerAug 28Clinical readoutautogene cevumeranBioNTech SE
Roche registers two Phase II trials of RO7568282 in Parkinson's and Alzheimer's diseaseAug 24Weekly roundup, 2 itemsRO7568282Roche
Lilly registers Phase 3 depression trial; posts results for two psoriasis and oncology studiesAug 20Weekly roundup, 5 itemsabemaciclibbrenipatide
Roche's glofitamab Phase 2 trial in untreated DLBCL posts results after primary completionAug 18Trial updateglofitamabprednisone
Roche posts results for satralizumab TED trial; completes Ocrelizumab SC vs IV MS studyAug 12Weekly roundup, 2 itemsocrelizumabRoche
Roche results post for two terminated Morpheus umbrella trials; new Phase 1/2 studies registeredAug 7Weekly roundup, 6 itemsatezolizumabBioLineRx, Ltd.
Lineage reports Q2 2026 results, advances COR1 corneal program and OpRegen dataAug 6Quarterly updateLineage Cell Therapeutics, Inc.Opregen
Recursion posts Q2 2026 results, Genentech advances first neuroscience targetAug 5Quarterly updateRecursion Pharmaceuticals, Inc.Roche
Roche's SatraGO-1 posts completed Phase III results; CellCept gets four-formulation label updateJul 31Weekly roundup, 5 itemsmycophenolate mofetilRoche
Ocrevus higher-dose Phase 3 posts results, misses primary endpoint; two partner trials updateJul 24Weekly roundup, 4 itemsobinutuzumabocrelizumab
Roche posts results for two Phase 3 lebrikizumab asthma trials; Operetta 2 update on pediatric MSJul 17Weekly roundup, 3 itemslebrikizumabocrelizumab
Nurix strikes $2.3 billion Roche pact for BTK degrader bexobrutidegJul 9Quarterly updatebexobrutidegNurix Therapeutics, Inc.
Roche's lebrikizumab asthma trial posts results; new faricimab trial planned for eye diseaseJul 2Weekly roundup, 2 itemsfaricimablebrikizumab
Sign in